Molecular Epidemiology of Multidrug-resistant Escherichia coli from Urinary Tract Infections

Year 2021, Volume: 11 Issue: 02, 66 - 73, 15.06.2021

Divya Sukumaran Mohamed Hatha

https://doi.org/10.5799/jmid.951495

Abstract

Objectives: The purpose of this study was to investigate the phylogenetic groups, antibiotic resistance, antibiotic resistance genes (ARGs), integrons, extraintestinal virulence genes and genetic diversity of Escherichia coli isolates from human urinary tract infection.
Methods: A total of 100 E. coli isolates were collected from patients with urinary tract infections in Kerala, South India. Antibiotic susceptibility testing of all E. coli isolates against different antibiotics was determined by the disc diffusion method. Phylogenetic groups, extraintestinal virulence genes, ARGs, and integrons were detected by PCR. Enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) was used to check the genetic relatedness among E. coli isolates.
Results: E. coli isolates have mainly belonged to phylogenetic group B2. Resistance to ampicillin was most frequent among the E. coli isolates followed by resistance to cefoxitin, cefpodoxime, nalidixic acid, trimethoprim, and co-trimoxazole. Among E. coli isolates, 96% were multidrug-resistant (MDR), and 86% and 32% harbored ARGs and integrase 1 (int1) respectively. Seventy-nine percent of the isolates were extraintestinal pathogenic E. coli (ExPEC), and 86% of them (n = 68) harbored ARGs. One extensively drug-resistant (XDR) ExPEC was obtained in this study. The present study revealed a significant association between the presence of virulence genes and antibiotic resistance. A high degree of genetic diversity was observed among the ARGs-harboring E. coli isolates.
Conclusion: Understanding the association between extraintestinal virulence genes and antibiotic resistance genes would result in the proper treatment of urinary tract infections. J Microbiol Infect Dis 2021; 11(2):66-73.

Keywords

antibiotic resistance,, ExPEC,, India, Escherichia coli,

References

• 1. WHO. Critically important antimicrobials for human medicine 5th revision. World Health Organization, Geneva, Switzerland. http://who.int/foodsafety/ publications/antimicrobials-fifth/en/. 2017. (accessed 21.06.20).
• 2. Ewers C, Li G, Wilking H, Kiessling S, et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: How closely related are they? Int J Med Microbiol 2007;297: 163–176.
• 3. Barrow GI, Feltham RKA. Cowan and Steel’s manual for the identification of medical bacteria.1993:317.
• 4. Bej AK, Dicesare JL, Haff L, et al. Detection of Escherichia coli and Shigella spp. in water by using the polymerase chain reaction and gene probes for uid. Appl Environ Microbiol 1991;57: 1013–1017.
• 5. Sambrook J, Fritsch E, Maniatis V. Molecular Cloning. A Laboratory Manual. New York: Cold spring Harbor Laboratory Press.1989.
• 6. Clermont O, Christenson JK, Denamur E, et al. The Clermont Escherichia coli phylo-typing method revisited: Improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep 2013;5: 58–65.
• 7. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181:261–272.
• 8. Bauer AW, Kirby WMM, Skerris JC, et al. Antibiotic susceptibility testing by a standardized single diffusion method. Am J Clin Pathol 1966;454: 493–496.
• 9. CLSI. Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI Document M100-S22, Clinical and Laboratory Standard Institute, Wayne, 2012.
• 10. Krumperman PH. Multiple Antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl Environ Microbiol 1983; 46:165–170.
• 11. Maynard C, Fairbrother JM, Bekal S, et al. Antimicrobial resistance genes in enterotoxigenic Escherichia coli O149:K91 isolates obtained over a 23-year period from pigs. Antimicrob Agents Chemother 2003; 47:3214–3221.
• 12. Dallenne C, da Costa A, Decré D, et al. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010; 65:490–495.
• 13. Batchelor M, Hopkins K, Threlfall EJ, et al. blaCTX-M genes in clinical Salmonella isolates recovered from humans in england and wales from 1992 to 2003. Antimicrob Agents Chemother 2005; 49:1319–1322.
• 14. Rosengren LB, Waldner CL, Reid-Smith RJ. Associations between antimicrobial resistance phenotypes, antimicrobial resistance genes, and virulence genes of fecal Escherichia coli isolates from healthy grow-finish pigs. Appl Environ Microbiol 2009; 75:1373–1380.
• 15. Navia MM, Ruiz J, Sanchez-Cespedes J, et al. Detection of dihydrofolate reductase genes by PCR and RFLP. Diagn Microbiol Infect Dis 2003; 46:295–298.
• 16. Cattoir V, Poirel L, Rotimi V, et al. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007; 60:394–397.
• 17. Benaicha H, Barrijal S, Ezzakkioui F, et al. Prevalence of PMQR genes in E. coli and Klebsiella spp. isolated from North-West of Morocco. J Glob Antimicrob Resist 2017; 10:321–325.
• 18. Kim KY, Park JH, Kwak HS, et al. Characterization of the quinolone resistance mechanism in foodborne Salmonella isolates with high nalidixic acid resistance. Int J Food Microbiol 2011; 146:52–56.
• 19. Kraft CA, Timbury MC, Platt DJ. Distribution and genetic location of Tn7 in trimethoprim-resistant Escherichia coli. J Med Microbiol 1986; 22:125–131.
• 20. Goldstein C, Lee MD, Sanchez S, et al. Incidence of class 1 and 2 integrases in clinical and commensal bacteria from livestock, companion animals, and exotics. Antimicrob Agents Chemother 2001; 45:723–726.
• 21. Meacham KJ, Zhang L, Foxman B, et al. Evaluation of genotyping large numbers of Escherichia coli isolates by enterobacterial repetitive intergenic consensus-PCR. J Clin Microbiol 2003; 41:5224–5226. http://jcm.asm.org/content/41/11/5224.full.
• 22. Chakraborty A, Adhikari P, Shenoy S, et al. Molecular characterization and clinical significance of extraintestinal pathogenic Escherichia coli recovered from a south Indian tertiary care hospital. Microb Pathog 2016; 95:43–48.
• 23. Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 2005; 295:383–404.
• 24. van Hoek AHAM, Stalenhoef JE, van Duijkeren E, et al. Comparative virulotyping of extended-spectrum cephalosporin-resistant E. coli isolated from broilers, humans on broiler farms and in the general population and UTI patients. Vet Microbiol 2016; 194:55–61.
• 25. Shahbazi S, Asadi KMR, Habibi M, et al. Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. J Glob Antimicrob Resist 2018; 14:118–125.
• 26. Al-Agamy MH, Aljallal A, Radwan HH, et al. Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals. J Infect Public Health 2018; 11:64–68.